Polatuzumab Vedotin: Current Role and Future Applications in the Treatment of Patients with Diffuse Large B-Cell Lymphoma
Diffuse large B-cell lymphoma (DLBCL) is a biologically and clinically heterogeneous disease. Despite good responses to standard of care frontline chemoimmunotherapy, the prognosis of relapsed/refractory (R/R) patients remains obscured by the possible inadequate responses to salvage therapy, eligibi...
Sparad:
| Huvudupphov: | , , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
SAABRON PRESS
2021-03-01
|
| Serie: | Clinical Hematology International |
| Ämnen: | |
| Länkar: | https://www.atlantis-press.com/article/125953899/view |
| Taggar: |
Inga taggar, Lägg till första taggen!
|